1 / 4

European Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026

The European neurological disorder drug market is projected to grow at a significant CAGR during the forecast period (2020-2026). The key factors driving the growth of the market include the rising prevalence of neurological disorders among the people across the region.

mansi3210
Download Presentation

European Neurological Disorder Drugs Market Size, Industry Trends, Share and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Orion Market Research European Neurological Disorder Drugs Market, Size, Share, Analysis Report & Forecast to 2026 Request https://www.omrglobal.com/request-sample/european-neurological-disorder-drugs-market a Free Sample of our European Neurological Disorder Drugs Market: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The European neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). The key factors that primarily flourish the growth of the market include the rising geriatric population along with the rising prevalence of neurological disorders. As per the European Academy of Neurology 2019, around 60% of the population suffers from any one of the neurological disorders, and there is an increased burden of deaths and cases of neurological diseases. A https://www.omrglobal.com/industry-reports/european-neurological-disorder-drugs-market full Report of European Neurological Disorder Drugs Market is Available at: The European Academy of Neurology divided Europe into five major regions, which include, European Union (EU28), Western Europe, Central Europe, Eastern Europe, and WHO region Europe. The prevalence of neurological disorders in the EU28 is 307 million in which there were more than 1.1 million mortalities; the prevalence in Western Europe was 260 million with 0.8 million mortalities, and Central Europe has a prevalence of 67 million with 0.3 million mortalities. While Eastern Europe with a prevalence of 130 million and 0.6 mortalities, while the WHO region Europe has a total prevalence of 542 million with more than 1.9 million mortalities. Such an increased prevalence of disorders among the people in the region is the primary factor creating scope for the European neurological disorder drugs industry growth over the forecast period. Request https://www.omrglobal.com/request-sample/european-neurological-disorder-drugs-market a Free Sample of our European Neurological Disorder Drugs Market: Besides, the presence of the key players also supports the growth of the European neurological disorder drugs market. Players such as Novartis International AG, Allergan Plc., AstraZeneca Plc, and Boehringer Ingelheim International GmbH are significantly contributing to the market growth. Market Coverage       Market number available for – 2019-2026 Base year- 2019 Forecast period- 2020-2026 Segment Covered- By Disorder Type Region Covered- Europe Competitive Landscape- Novartis International AG, Allergan Plc., AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, and F. Hoffmann-La Roche Ltd. Key questions addressed by the report     What is the market growth rate? Which segment dominates the market in the base year? Which segment will project the fastest growth in the market? How COVID-19 impacted the market? o Recovery Timeline o Deviation from the pre-COVID-19 forecast

  3. o Most affected segment    Who is the leader in the market? How players are addressing challenges to sustain growth? Where is the investment opportunity? Europe Neurological Disorder Drugs Market – Segmentation By Disorder Type       Epilepsy Alzheimer’s Disease Parkinson’s Disease Multiple Sclerosis Huntington Disease Others Europe Neurological Disorder Drugs Market – Countries Covered       UK Germany France Italy Spain Rest of Europe Company Profiles            Allergan Plc AstraZeneca Plc Bayer AG Boehringer Ingelheim International GmbH Eli Lilly and Co. F. Hoffmann-La Roche Ltd. GlaxoSmithKline Plc Novartis International AG Sanofi SA Sun Pharmaceutical Industries Ltd. Teva Pharmaceutical Industries Ltd For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/european-neurological-disorder-drugs-market About Orion Market Research

  4. Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related